Raphael Darteil
25Patents
5h-index
32Co-inventors
69Inventor score
Filing activity: Jan 5, 1995 → Jul 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8772342B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Human Necessities | 34 | Active |
| US5980906A | Live recombinant avian vaccine using an avian herpesvirus as vector | Chemistry; Metallurgy | 25 | Expired |
| US5733554A | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease | Chemistry; Metallurgy | 14 | Expired |
| US8895619B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Human Necessities | 6 | Active |
| US9221751B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 5 | Active |
| US6045803A | Live recombinant avian vaccine using an avian herpesvirus as vector | Chemistry; Metallurgy | 5 | Expired |
| US5676952A | Herpesviruses transformed to express GD in vitro | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9585853B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 3 | Active |
| US9782373B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 2 | Active |
| US10350181B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 1 | Active |
| US10117855B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10130613B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US6096535A | Feline infectious peritonitis vaccine | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6358512B1 | Feline infectious peritonitis vaccine | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10117856B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US6080850A | Feline infectious peritonitis vaccine | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7253296B2 | Acylated aminopropanediols and analogues and therapeutic uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US10130612B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10905680B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10722575B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 0 | Active |
| US10022343B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 0 | Active |
| US12104209B2 | Non-invasive diagnostic of non-alcoholic steatohepatitis | Physics | 0 | Active |
| US11371098B2 | Methods for diagnosing and evaluating non-alcoholic steatohepatitis | Physics | 0 | Active |
| US12030861B1 | L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereof | Chemistry; Metallurgy | 0 | Active |
| US11103484B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.